[DNA analysis in classic phenylketonuria--screening for mutations and haplotype analysis in Slovak families]. 1994

L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
Ustav molekulárnej fyziológie a genetiky SAV v Bratislave.

Authors in this contribution present the results of screening for mutations in PAH gene responsible for classical phenylketonuria (PKU), and that of haplotype analysis, based on DNA analysis in 49 Caucasian families with at least one affected child from Slovak Republic. The clearly predominant PKU mutation in this population was the R408W with proportion of 45.9% among all PKU mutations. In addition four other mutations have been identified: IVS12nt1-10.2%, R158Q-7.1%, R261Q-7.1%, and R252W-2.0%. the overall proportion of identified PKU mutations equals 72.4%. Considering the fact, that these mutations are amenable to rapid and rather simple detection using PCR, the DNA analysis is recommended as a method of direct diagnosis in clinical practice as well as in prevention.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010651 Phenylalanine Hydroxylase An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1. Phenylalanine 4-Hydroxylase,Phenylalanine 4-Monooxygenase,4-Hydroxylase, Phenylalanine,4-Monooxygenase, Phenylalanine,Hydroxylase, Phenylalanine,Phenylalanine 4 Hydroxylase,Phenylalanine 4 Monooxygenase
D010661 Phenylketonurias A group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme PHENYLALANINE HYDROXYLASE or less frequently by reduced activity of DIHYDROPTERIDINE REDUCTASE (i.e., atypical phenylketonuria). Classical phenylketonuria is caused by a severe deficiency of phenylalanine hydroxylase and presents in infancy with developmental delay; SEIZURES; skin HYPOPIGMENTATION; ECZEMA; and demyelination in the central nervous system. (From Adams et al., Principles of Neurology, 6th ed, p952). Biopterin Deficiency,Dihydropteridine Reductase Deficiency Disease,Hyperphenylalaninemia, Non-Phenylketonuric,Phenylalanine Hydroxylase Deficiency Disease,BH4 Deficiency,DHPR Deficiency,Deficiency Disease, Dihydropteridine Reductase,Deficiency Disease, Phenylalanine Hydroxylase,Deficiency Disease, Phenylalanine Hydroxylase, Severe,Dihydropteridine Reductase Deficiency,Folling Disease,Folling's Disease,HPABH4C,Hyperphenylalaninaemia,Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism,Hyperphenylalaninemia, BH4-Deficient, C,Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency,Non-Phenylketonuric Hyperphenylalaninemia,Oligophrenia Phenylpyruvica,PAH Deficiency,PKU, Atypical,Phenylalanine Hydroxylase Deficiency,Phenylalanine Hydroxylase Deficiency Disease, Severe,Phenylketonuria,Phenylketonuria I,Phenylketonuria II,Phenylketonuria Type 2,Phenylketonuria, Atypical,Phenylketonuria, Classical,QDPR Deficiency,Quinoid Dihydropteridine Reductase Deficiency,Tetrahydrobiopterin Deficiency,Atypical PKU,Atypical Phenylketonuria,Biopterin Deficiencies,Classical Phenylketonuria,Deficiency, BH4,Deficiency, Biopterin,Deficiency, DHPR,Deficiency, Dihydropteridine Reductase,Deficiency, PAH,Deficiency, Phenylalanine Hydroxylase,Deficiency, QDPR,Deficiency, Tetrahydrobiopterin,Disease, Folling,Disease, Folling's,Hyperphenylalaninemia, Non Phenylketonuric,Non Phenylketonuric Hyperphenylalaninemia,Non-Phenylketonuric Hyperphenylalaninemias
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
January 2012, Journal of genetics,
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
January 1989, Acta biochimica Polonica,
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
August 1989, Clinical genetics,
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
March 1985, Lancet (London, England),
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
March 1988, Lancet (London, England),
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
March 1992, Clinical genetics,
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
January 1998, Human mutation,
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
January 1991, Advances in experimental medicine and biology,
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
October 1987, Archives francaises de pediatrie,
L Kádasi, and H Poláková, and E Feráková, and T Krivusová, and S Hudecová, and I Szomolayová, and J Strnová, and I Hruskovic, and V Ferák
June 1989, Prenatal diagnosis,
Copied contents to your clipboard!